Financials

  • Market Capitalization 21.49 M
  • Employee 38
  • Founded 2014
  • CEO N/A
  • Website www.longeveron.com
  • Headquarter Delaware, United States
  • FIGI BBG00YZ6JHT4
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.91
Relación precio/flujo de caja
15.92 K

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4533
KZIA
Kazia Therapeutics Limited - American Depositary Shares
13.88 USD-0.50%+13.31%+1.76%+137.26%22.47 M USD
4544
DARE
Dare Bioscience, Inc. - Common Stock
1.44 USD+5.88%+9.09%-28.00%-12.73%21.57 M USD
4551
CLRB
Cellectar Biosciences, Inc. - Common Stock
2.65 USD+1.92%-0.38%-5.69%-15.61%21.18 M USD
4557
GRDX
GridAI Technologies Corp. - Common Stock
3.15 USD+5.70%+11.31%-29.21%+23.53%20.96 M USD

Noticias